Ajanta Pharma Q3 Results
- BSE: 532331
- NSE: AJANTPHARM
- ISIN: INE031B01049
- Sector: Biotechnology & Drugs
BSE
3,431.40
-21.55 (-0.62%)
-21.55 (-0.62%)Volume5.57 K
Updated: Thu 16 Jul, 2026 | 15:29:00
NSE
3,452.80-1.40 (-0.04%)
-1.40 (-0.04%)Volume1.12 L
Updated: Thu 16 Jul, 2026 | 15:43:17
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Ajanta Pharma Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,036.11 | 884.21 | 0.80% | 861.27 | 20.30% |
| Depreciation/ Amortization | 43.51 | 34.39 | 1.26% | 35.97 | 20.96% |
| Operating Income | 338.73 | 302.43 | 3.97% | 284.86 | 18.91% |
| Net Income | 273.77 | 216.48 | 5.22% | 232.88 | 17.56% |
| Other Operating Expenses Total | 375.82 | 327.18 | 7.03% | 302.32 | 24.31% |
| Net Income Before Taxes | 358.60 | 290.24 | 5.22% | 307.39 | 16.66% |
| Total Revenue | 1,374.84 | 1,186.64 | 1.56% | 1,146.13 | 19.95% |
| Selling/ General/ Admin Expenses Total | 330.52 | 260.96 | 4.26% | 265.17 | 24.64% |
| Diluted Normalized EPS | 21.91 | 17.26 | 5.18% | 18.59 | 17.86% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.